TY  -  JOUR
AU  -  Zavaleta-Monestel, Esteban
AU  -  Monge-Bogantes, Luis Carlos
AU  -  Arguedas-Chacón, Sebastián
AU  -  Martínez-Vargas, Ernesto
AU  -  Arrieta-Vega, Dina
AU  -  Langella, Roberto
AU  -  Zovi, Andrea
T1  -  Role of the clinical pharmacist in the use of biologics for the treatment of rheumatologic diseases
PY  -  2024
Y1  -  2024-10-01
DO  -  10.1721/4417.44134
JO  -  Giornale Italiano di Farmacia Clinica
JA  -  GIFAC
VL  -  38
IS  -  4
SP  -  140
EP  -  146
PB  -  Il Pensiero Scientifico Editore
SN  -  1120-3749
Y2  -  2026/04/30
UR  -  http://dx.doi.org/10.1721/4417.44134
N2  -  Summary. Biological medications have revolutionized pharmacotherapy, particularly in patients with rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The effectiveness of these therapeutic agents largely depends on patient adherence, as they, like other medications, can cause adverse effects that significantly contribute to treatment discontinuation among a substantial number of patients. In this context, clinical pharmacists play a crucial role as medication specialists, providing patient education, monitoring drug administration, and conducting pharmacotherapeutic follow-ups. These interventions enhance treatment quality, improve patient quality of life and therapeutic outcomes.
ER  -